Metformin group
Sponsors
Maria Sandberg Westerstahl, Centre Hospitalier Universitaire de Nice, Xiang Guang-da, J JESUS VENEGAS, MD, Hassan Aly Hassan Elmaghraby
Conditions
Cardiovascular DiseasesEndothelial FunctionInsulin ResistanceLVMMetastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)Nutritional, Metabolic, Endocrine
Fertility-female
Polycystic ovarian syndromeNutritional, Metabolic, Endocrine
Pregnancy and Childbirth
Gestational diabetesPreeclamsia
Phase 2
Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma
CompletedNCT01840007
Start: 2011-08-30End: 2015-11-18Updated: 2026-03-31
Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.
CompletedNCT04148183
Start: 2004-01-01End: 2009-01-01Updated: 2019-11-05
Phase 4
Unknown Phase
Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents
TerminatedNCT00889876
Start: 2009-02-28End: 2015-12-31Updated: 2023-04-04
Comparing the effects of metformin versus combined Contraceptive pills in adolescent PCOS
Active, not recruitingPACTR201307000567163
Start: 2010-02-15Target: 120Updated: 2026-01-27
Gestational diabetes mellitus
Active, not recruitingPACTR201610001801760
Start: 2016-10-16Target: 120Updated: 2026-01-27
Metformin versus Levonorgestrel-Releasing Intrauterine Device (MIRENA) in the Management of Endometrial Hyperplasia
Active, not recruitingPACTR201908498370196
Start: 2019-08-25Target: 50Updated: 2026-01-27
A randomized controlled trial on the effectiveness of Metformin for prevention of Preeclampsia in Abubakar Tafawa Balewa University teaching hospital Bauchi, Nigeria.
RecruitingPACTR202405860574489
Start: 2023-02-01Target: 140Updated: 2026-01-27